Weak legislation and a lax distribution system have been identified as responsible for the growing drug counterfeiting business in Nigeria from which the country loses an estimated N200 billion annually.
Aside the economic loss, the damage caused by counterfeit medicines on consumers’ wellbeing a
```
Members Only
Login or create an account to continue
This article is available to registered BusinessDay readers. Please login if you already have an account, or create a new account to continue reading.
New to BusinessDay? Register now and start reading.
```
BusinessDay
Nigeria's leading finance and market intelligence news report. Also home to expert opinion and commentary on politics, sports, lifestyle, and more
